109 related articles for article (PubMed ID: 8461030)
1. Protection of erythrocytes against hemolytic agents by cyclodextrin polysulfate.
Weisz PB; Kumor K; Macarak EJ
Biochem Pharmacol; 1993 Mar; 45(5):1011-6. PubMed ID: 8461030
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the inclusion mode of beta-cyclodextrin sulfate and its effect on the chlorpromazine-induced hemolysis of rabbit erythrocytes.
Shiotani K; Uehata K; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2332-7. PubMed ID: 7859332
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of cyclodextrins on drug-induced hemolysis in vitro.
Uekama K; Irie T; Sunada M; Otagiri M; Tsubaki K
J Pharmacobiodyn; 1981 Feb; 4(2):142-4. PubMed ID: 7277200
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced hemolysis in vitro.
Nagase Y; Hirata M; Arima H; Tajiri S; Nishimoto Y; Hirayama F; Irie T; Uekama K
J Pharm Sci; 2002 Nov; 91(11):2382-9. PubMed ID: 12379923
[TBL] [Abstract][Full Text] [Related]
5. Protective mechanism of beta-cyclodextrin for the hemolysis induced with phenothiazine neuroleptics in vitro.
Irie T; Sunada M; Otagiri M; Uekama K
J Pharmacobiodyn; 1983 Jun; 6(6):408-14. PubMed ID: 6138401
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
Irie T; Otagiri M; Sunada M; Uekama K; Ohtani Y; Yamada Y; Sugiyama Y
J Pharmacobiodyn; 1982 Sep; 5(9):741-4. PubMed ID: 7153847
[TBL] [Abstract][Full Text] [Related]
7. Sulfation and hemolytic activity of cyclodextrin.
Macarak EJ; Kumor K; Weisz PB
Biochem Pharmacol; 1991 Sep; 42(7):1502-3. PubMed ID: 1930277
[No Abstract] [Full Text] [Related]
8. Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses.
Uekama K; Irie T; Sunada M; Otagiri M; Iwasaki K; Okano Y; Miyata T; Kasé Y
J Pharm Pharmacol; 1981 Nov; 33(11):707-10. PubMed ID: 6118408
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of neutral amino acids against amphipathic drug-induced hemolysis.
Morimoto Y; Yutani Y; Kado Y; Iida T; Shiota M; Takeuchi Y
Biol Pharm Bull; 1995 Nov; 18(11):1535-8. PubMed ID: 8593474
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes.
Ohtani Y; Irie T; Uekama K; Fukunaga K; Pitha J
Eur J Biochem; 1989 Dec; 186(1-2):17-22. PubMed ID: 2598927
[TBL] [Abstract][Full Text] [Related]
11. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure.
Cruz Silva MM; Madeira VM; Almeida LM; Custódio JB
Biochim Biophys Acta; 2000 Mar; 1464(1):49-61. PubMed ID: 10704919
[TBL] [Abstract][Full Text] [Related]
12. Protection of erythrocytes against organometals-induced hemolysis.
Kleszczyńska H; Bonarska D; Sarapuk J; Przestalski S
J Fluoresc; 2004 Jan; 14(1):5-10. PubMed ID: 15622854
[TBL] [Abstract][Full Text] [Related]
13. [The effect of chlorpromazine on the temperature and osmotic sensitivity of erythrocytes].
Shpakova NM; Bondarenko VA
Biokhimiia; 1991 Dec; 56(12):2125-30. PubMed ID: 1807402
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical and biological properties of 6(1),6(3),6(5)-tri-O-alpha-maltosyl-cyclomaltoheptaose (6(1),6(3),6(5)-tri-O-alpha-maltosyl-beta-cyclodextrin).
Okada Y; Semma M; Ichikawa A
Carbohydr Res; 2007 Jul; 342(10):1315-22. PubMed ID: 17498674
[TBL] [Abstract][Full Text] [Related]
15. Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells. Implications for malarial therapy.
Crandall IE; Szarek WA; Vlahakis JZ; Xu Y; Vohra R; Sui J; Kisilevsky R
Biochem Pharmacol; 2007 Mar; 73(5):632-42. PubMed ID: 17166484
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical and biological properties of 2-O-α-D-galactosyl-cyclomaltohexaose (α-cyclodexterin) and -cyclomaltoheptaose (β-cyclodextrin).
Okada Y; Semma M; Ichikawa A
Carbohydr Res; 2011 Jun; 346(8):1018-22. PubMed ID: 21477794
[TBL] [Abstract][Full Text] [Related]
17. [Antihemolytic effect of various benzodiazepines on human erythrocytes].
Terhaag B; Bockisch A
Acta Biol Med Ger; 1976; 35(10):1415-7. PubMed ID: 14466
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hemolysis by tricyclic dyestuffs--fluorescein-phenothiazine antagonism.
Baur EW
Biochem Pharmacol; 1973 Jun; 22(12):1509-16. PubMed ID: 4732527
[No Abstract] [Full Text] [Related]
19. Interaction of per 3,6-anhydro-alpha cyclodextrins (alpha 36CD) and lead-alpha 36CD complex with biological systems.
Debouzy JC; Fauvelle F; Gadelle A; Baudin C; Richard M; Perly B; Chouteau F; Joets J; Tazz JJ; Daveloose D
Boll Chim Farm; 1998 May; 137(5):144-51. PubMed ID: 9689900
[TBL] [Abstract][Full Text] [Related]
20. Hemolysis of erythrocytes by primary pharmacologic agents, part 2: influence of the vehicle.
Ansel HC; Gigandet MP
Am J Hosp Pharm; 1976 Dec; 33(12):1264-7. PubMed ID: 11686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
